Skip to main content
Premium Trial:

Request an Annual Quote

Invitrogen Licenses Geron’s Patents on Human Embryonic Stem Cells

NEW YORK, June 29 (GenomeWeb News) - Geron licensed its intellectual property related to the growth of human embryonic stem cells to Invitrogen, Invitrogen said today.

 

Under the non-exclusive license agreement, Invitrogen can use Geron's patents to develop, manufacture, and sell media, additives, and reagents for use by hESC researchers. Some commercial use restrictions apply.

 

Invitrogen can also sublicense the products to its customers for research use only. Geron will receive license payments and royalties on products developed using the patents.

 

The license involves patents covering the growth of hESCs in the absence of feeder cells, and those covering specific media formulations for such feeder-free growth.

 

Additional financial details were not disclosed.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.